Valuation: Inotiv, Inc.

Market Cap 387K 338K 312K 288K 543K 37.29M 555K 3.73M 1.47M 18.26M 1.45M 1.42M 62.88M P/E 2024
-0.41x
P/E 2025 -0.69x
Enterprise Value 438M 383M 353M 326M 614M 42.17B 627M 4.22B 1.66B 20.65B 1.64B 1.61B 71.1B EV / Sales 2024
0.95x
EV / Sales 2025 0.95x
Free-Float
91.39%
Yield 2024 *
-
Yield 2025 -
1 day-26.00%
1 week-38.33%
Current month+7.77%
1 month-36.57%
3 months-95.99%
6 months-98.05%
Current year-98.03%
1 week 0.01
Extreme 0.011
0.03
1 month 0.01
Extreme 0.007
0.03
Current year 0.01
Extreme 0.007
0.65
1 year 0.01
Extreme 0.007
2.44
3 years 0.01
Extreme 0.007
11.42
5 years 0.01
Extreme 0.007
60.66
10 years 0.01
Extreme 0.007
60.66
Manager TitleAgeSince
Chief Executive Officer 67 12/01/2019
Director of Finance/CFO 61 06/03/2020
Compliance Officer 49 23/10/2023
Director TitleAgeSince
Chairman 71 26/03/2024
Director/Board Member 60 02/07/2018
Director/Board Member 67 12/01/2019
Date Insider Type Main position Quantity % Market Cap.
18/6/26 Tax

Chief Operating Officer

-5,769 0.0165%
18/6/26 Tax

Compliance Officer

-5,800 0.0166%
18/6/26 Tax

Executive/Senior Manager

-5,371 0.0154%
Change 5-day change 1-year change 3-year change Capi.($)
-26.00%-38.33%-99.37%-99.78% 387K
+3.90%-0.39%+376.72%+599.59% 39.58B
-1.70%+4.46%+7.46%+57.67% 34.69B
-2.01%-0.76%+26.35%-6.83% 34.42B
+0.06%+0.34%+2.32%+29.30% 27.11B
+0.46%-3.49% - - 16.21B
-0.04%-0.09%+68.48%+117.39% 15.36B
+1.12%+1.91%+15.90%+19.65% 14.05B
0.00%+1.36%+15.74%-30.62% 13.02B
-0.08%-3.01%+1,271.69%+649.69% 11.76B
Average -2.43%-3.80%+187.25%+148.45% 20.62B
Weighted average by Cap. +0.24%+0.36%+171.43%+187.42%

Financials

2024 2025
Net sales 491M 429M 396M 365M 688M 47.26B 703M 4.73B 1.86B 23.15B 1.84B 1.8B 79.68B 513M 448M 414M 381M 719M 49.4B 735M 4.94B 1.94B 24.2B 1.93B 1.88B 83.3B
Net income -108M -94.77M -87.45M -80.61M -152M -10.44B -155M -1.05B -411M -5.11B -407M -398M -17.61B -68.62M -59.97M -55.34M -51.01M -96.14M -6.61B -98.28M -661M -260M -3.24B -258M -252M -11.14B
Net Debt 424M 370M 342M 315M 594M 40.8B 607M 4.08B 1.61B 19.98B 1.59B 1.56B 68.79B 438M 382M 353M 325M 613M 42.14B 627M 4.22B 1.66B 20.64B 1.64B 1.61B 71.04B
Logo Inotiv, Inc.
Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Employees
1,996
Date Price Change Volume
17/07/26 USD 0.0111 -26.00% 243,786
16/07/26 USD 0.0150 +32.74% 70,600
15/07/26 USD 0.0113 -13.08% 630,714
14/07/26 USD 0.0130 -26.97% 325,742
13/07/26 USD 0.0178 -1.11% 502,086
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOTVQ Stock